Death rates from ovarian cancer are predicted to fall by 17 percent in the UK and by 7 percent in EU countries in 2022 compared to 2017, according to new research published in the journal Annals of Oncology today.
Jan 26, 2022
0
32
Data from early clinical trials presented at the ESMO Congress 2021 suggest that new anticancer treatments are on the horizon, with a clear emphasis on precision medicine. Despite medical research suffering setbacks ...
Sep 24, 2021
0
18
The long-awaited confirmation of the efficacy of COVID-19 vaccination in patients with cancer has arrived, on time to be disseminated to a global audience at the annual congress of the European Society for Medical Oncology, ...
Sep 20, 2021
0
170
The first randomized study in malignant pheochromocytoma and paraganglioma (MPP) has found that sunitinib prolongs progression-free survival (PFS) by more than five months. The late breaking results of the FIRSTMAPPP trial ...
Sep 20, 2021
0
15
Previous standards of cancer follow-up care and support may no longer meet current needs as improvements in screening practices, early diagnosis and treatment of cancer have put long-term survival beyond five years following ...
Sep 20, 2021
0
3
The addition of immunotherapy to standard first-line treatment extends survival by eight months for patients with recurrent, persistent or metastatic cervical cancer, according to late breaking results from the KEYNOTE-826 ...
Sep 20, 2021
0
15
A novel combination of well-known drugs prolongs survival in patients with hormone/castration-sensitive prostate cancer, according to late breaking research presented at the ESMO Congress 2021. The PEACE-1 and STAMPEDE studies ...
Sep 20, 2021
0
0
The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, means it can be difficult for patients, the lay public as well as for doctors not specialized in oncology to keep up with the evolution ...
Sep 17, 2021
1
7
The announcement of a cancer diagnosis abruptly and durably alters the course of daily life—not just for the person receiving it, but also for their family. New research presented at the ESMO Congress 2021 suggests that ...
Sep 13, 2021
0
26
Final results from a study of a blood test that can detect more than 50 types of cancer have shown that it is accurate enough to be rolled out as a multi-cancer screening test among people at higher risk of the disease, including ...
Jun 25, 2021
0
5
